Principal Financial Group
GPCR icon

Principal Financial Group’s Structure Therapeutics GPCR Stock Holding History

Principal Financial Group’s Portfolio GPCR Stock Details GPCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$84.5M Buy
1,753,764
+469,554
+37% +$32.1M 0.05% 329
2025
Q4 		$89.3M Buy
1,284,210
+496,726
+63% +$20.3M 0.05% 304
2025
Q3 		$22M Sell
787,484
-65,718
-8% -$1.31M 0.01% 813
2025
Q2 		$17.7M Buy
853,202
+96,495
+13% +$2.12M 0.01% 903
2025
Q1 		$13.1M Sell
756,707
-34,427
-4% -$843K 0.01% 1111
2024
Q4 		$21.5M Buy
791,134
+245,775
+45% +$8.72M 0.01% 818
2024
Q3 		$23.9M Buy
545,359
+380,115
+230% +$14.7M 0.01% 748
2024
Q2 		$6.49M Buy
+165,244
New +$6.79M ﹤0.01% 1463

Other funds holding GPCR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $4.85B AUM 144% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
O
OrbiMed New York $4.59B AUM 125.28% 1-Year Est. Return